Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Stephan Kopytek"'
Autor:
Amer M. Zeidan, Daniel J. DeAngelo, Jeanne Palmer, Christopher S. Seet, Martin S. Tallman, Xin Wei, Heather Raymon, Priya Sriraman, Stephan Kopytek, Jan Philipp Bewersdorf, Michael R. Burgess, Kristen Hege, Wendy Stock
Publikováno v:
Ann Hematol
Annals of hematology, vol 101, iss 3
Annals of hematology, vol 101, iss 3
CC-90002 is an anti-CD47 antibody that inhibits CD47-SIRPα interaction and enables macrophage-mediated killing of tumor cells in hematological cancer cell lines. In this first clinical, phase 1, dose-escalation and -expansion study (CC-90002-AML-001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91f68a10cbb5afd2ba7d9f1d2b4832d5
https://europepmc.org/articles/PMC9414073/
https://europepmc.org/articles/PMC9414073/
Autor:
Diane Smith, Jessica Couch, Brian Short, David W. Brewster, David Jones, Ian Ragan, Emma Moore, Beatriz Silva Lima, Klaudia Hettinger, Petra M. Schmitt, Stephan Kopytek, Marilyn Hill, Rick Perry, Alan Broadmeadow, Alex Constan, David Jacobson-Kram, Markku Pasanen, Abby Jacobs, S.G. Moesgaard, Oliver Czupalla, Janet Clarke, Paul Brown, Leigh Ann Burns-Naas, Helga Lorenz, Matthias Festag, Kathryn Chapman, Lolke de Haan, Sally Robinson, Sue Sparrow, Andy Danks, Yvette van Bekkum, Paul Baldrick, Joseph J. DeGeorge, Fiona Sewell
Publikováno v:
Regulatory Toxicology and Pharmacology. 70(1):413-429
An international expert group which includes 30 organisations (pharmaceutical companies, contract research organisations, academic institutions and regulatory bodies) has shared data on the use of recovery animals in the assessment of pharmaceutical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10cea65f462843382ee771533e36a7db
